Abstract
AVNRT can be induced in the EP lab by atrial or ventricular stimulation in the basal state or after drug administration. The drug of choice is isoprenaline, but in some European countries, the lack of the drug demands efforts to search for other options. There is no study that compares efficacy of isoprenaline versus adrenaline for AVNRT induction in the EP lab. In our study we compared the two drugs in terms of efficacy and side effects.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Choi EK, Kumar S, Nagashima K, Lin KY, Barbhaiya CR, Chinitz JS, et al. Better outcome of ablation for sustained outflow-tract ventricular tachycardia when tachycardia is inducible. Europace. 2015;17:1571–9.
Hariman RJ, Gomes JA, El-Sherif N. Catecholamine-dependent atrioventricular nodal reentrant tachycardia. Circulation. 1983;67:681–6.
Toda I, Kawahara T, Murakawa Y, Nozaki A, Kawakubo K, Inoue H, et al. Electrophysiologial study of young patients with exercise related paroxysmal of palpitation: role of atropine and isoprenaline for initiation of supraventricular tachycardia. Br Heart J. 1989;61:268–73.
Huycke EC, Lai WT, Nguyen NX, Keung EC, Sung RJ. Role of intravenous isoproterenol in the electrophysiological induction of atrioventricular node reentrant tachycardia in patients with dual atrioventricular node pathways. Am J Cardiol. 1989;64:1131–7.
Brembilla-Perrot B, Terrier de la Chaise A, Pichene M, Aliot E, Cherrier F, Pernot C. Isoprenaline as an aid to the induction of catecholamine dependent supraventricular tachycardia during programmed stimulation. Br Heart J. 1989;61:348–55.
Stellbrink C, Diem B, Schauerte P, Brehmer K, Schuett H, Hanrath P. Differential effects of atropine and isoproterenol on inducibility of atrioventricular nodal reentrant tachycardia. J Interv Card Electrophysiol. 2001;5:463–9.
Katz DF, Hegeman TW, Aleong R. Use of isoproterenol for assessment of anterograde accessory pathway conduction properties in sedated asymptomatic patients with ventricular pre-excitation. J Innov Card Rhythm Manage. 2013;4:1428–33.
Oral H, Crawford T, Frederick M, Gadeela N, Wimmer A, Dey S, et al. Inducibility of paroxysmal atrial fibrillation by isoproterenol and its relation to the mode of onset of atrial fibrillation. J Cardiovasc Electrophysiol. 2008;19:466–70.
Cismaru G, Rosu R, Muresan L, Puiu M, Andronache M, Hengan E, et al. The value of adrenaline in the induction of supraventricular tachycardia in the EP lab. Europace. 2014;16:1634–8.
Calkins H, Sousa J, El-Atassi R, Schamltz S, Kadish A, Morady F. Reversal of antiarrhythmic drug effects by epinephrine: quinidine versus amiodarone. Am J Cardiol. 1992;19:347–52.
Jazayeri M, VanWyhe G, Avitall B, McKinnie J, Tchou P, Akhtar M. Isoproterenol reversal of antiarrhythmic effects in patients with inducible sustained ventricular tachyarrhythmias. J Am Coll Cardiol. 1989;14:705–11.
Markel ML, Miles WM, Prytowsky EN. The differential effects of isoproterenol on sustained ventricular tachycardia before and during antiarrhythmic therapy. J Am Coll Cardiol. 1987;9:227–8.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Cismaru, A. (2019). Adrenaline Versus Isoprenaline for Arrhythmia Induction. In: Cismaru, G. (eds) Arrhythmia Induction in the EP Lab. Springer, Cham. https://doi.org/10.1007/978-3-319-92729-9_11
Download citation
DOI: https://doi.org/10.1007/978-3-319-92729-9_11
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-92728-2
Online ISBN: 978-3-319-92729-9
eBook Packages: MedicineMedicine (R0)